Unknown

Dataset Information

Capilliposide from Lysimachia capillipes promotes terminal differentiations and reverses paclitaxel resistance in A2780T cells of human ovarian cancer by regulating Fos/Jun pathway.


ABSTRACT:

Objective

To investigate the potential effect of Lysimachia capillipes capilliposide (LCC) on the chemo sensitivity and the stemness of human ovarian cancer cells.

Methods

Cell Counting Kit-8 (CCK8) was used to measure the IC50 values. The apoptosis of cells was measured through flow cytometry. Evaluation of the stemness and differentiation markers was performed by the immunoblotting and the immunostaining assays. RNA-seq was performed through the Illumina HiSeq PE150 platform and differentially expressed genes (DEGs) were screened out through the bioinformation analysis. Overexpression or knockdown of Fos gene was achieved by shRNA transfection.

Results

Pre-exposure of A2780T cells with 10 μg/mL LCC sensitized them to paclitaxel, of which the

SUBMITTER: Zhang K 

PROVIDER: S-EPMC9476669 | biostudies-literature | 2022 Jan

REPOSITORIES: biostudies-literature